IINNW 0.00 Stock Price Inspira Technologies Oxy B.H.N. Ltd.
Range: | 0.13-0.85 | Vol Avg: | 4015 | Last Div: | 0 | Changes: | -0.24 |
Beta: | 2.09 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Wed Jul 14 2021 | Empoloyees: | 37 |
CUSIP: | M53637118 | CIK: | 0001837493 | ISIN: | IL0011761710 | Country: | IL |
CEO: | Mr. Dagi Shahar Ben-Noon | Website: | https://inspira-technologies.com |
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.